Media coverage
2
Media coverage
Title Epigenetic Drug CPI-0610 Called Clinically Active, Tolerable in Myelofibrosis - Cancer Therapy Advisor Media name/outlet Cancer Therapy Advisor Country/Territory United States Date 9/12/19 URL https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2019/myelofibrosis-tolerable-epigenetic-drug-cpi0610-clinically-active/ Persons John Mascarenhas Title Epigenetic Drug CPI-0610 Called Clinically Active, Tolerable in Myelofibrosis Media name/outlet Cancer Therapy Advisor Country/Territory United States Date 9/12/19 URL https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-hematology-ash/ash-2019/myelofibrosis-tolerable-epigenetic-drug-cpi0610-clinically-active/ Persons John Mascarenhas